Literature DB >> 2177540

Viral pneumonia in the first month of life.

M J Abzug1, A C Beam, E A Gyorkos, M J Levin.   

Abstract

We performed a 5-year review of 40 patients less than or equal to 30 days of age with viral pneumonia. Isolates included respiratory syncytial virus (55%), enteroviruses (15%), rhinoviruses (15%), adenoviruses (10%), parainfluenza virus (7.5%) and herpes simplex virus (5%). Most infants were previously healthy but had ill family members. Nine were born at less than 37 weeks of gestation. Symptoms and signs included tachypnea, decreased feeding, cough, cyanosis, lethargy, retractions, apnea, bradycardia, seizures and depressed consciousness. Seasonality and clinical features, but not radiographic patterns, suggested specific pathogens. Patients were moderately to severely ill. The median duration of hospitalization was 7 days; therapies administered included oxygen (90%), mechanical ventilation (45%), blood transfusions (25%) and supplemental oxygen after discharge (27%). The case fatality rate was 7.5%. Prematurity, ill appearance at presentation, lobar consolidation and adenovirus infection were risk factors for severe disease.

Entities:  

Mesh:

Year:  1990        PMID: 2177540     DOI: 10.1097/00006454-199012000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  21 in total

1.  Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Authors:  Tao Peng; Swathi Kotla; Roger E Bumgarner; Kurt E Gustin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Human rhinoviruses in severe respiratory disease in very low birth weight infants.

Authors:  E Kathryn Miller; Jimena Bugna; Romina Libster; Bryan E Shepherd; Paula M Scalzo; Patricio L Acosta; Diego Hijano; Natalia Reynoso; Juan P Batalle; Silvina Coviello; M Ines Klein; Gabriela Bauer; Alicia Benitez; Steven R Kleeberger; Fernando P Polack
Journal:  Pediatrics       Date:  2011-12-26       Impact factor: 7.124

3.  Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridization assay.

Authors:  S Blomqvist; A Skyttä; M Roivainen; T Hovi
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 4.  Isolation of adenovirus type 11 from the brain of a neonate with pneumonia and encephalitis.

Authors:  T Osamura; R Mizuta; H Yoshioka; S Fushiki
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

5.  Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study.

Authors:  Wen Kuan Liu; Qian Liu; De Hui Chen; Huan Xi Liang; Xiao Kai Chen; Mei Xin Chen; Shu Yan Qiu; Zi Yeng Yang; Rong Zhou
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

6.  Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real-Time PCR.

Authors:  Wenkuan Liu; Dehui Chen; Weiping Tan; Duo Xu; Shuyan Qiu; Zhiqi Zeng; Xiao Li; Rong Zhou
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  Human rhinoviruses: coming in from the cold.

Authors:  Katherine E Arden; Ian M Mackay
Journal:  Genome Med       Date:  2009-04-28       Impact factor: 11.117

8.  Population structure and evolution of Rhinoviruses.

Authors:  Vaishali P Waman; Pandurang S Kolekar; Mohan M Kale; Urmila Kulkarni-Kale
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

9.  Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses.

Authors:  Sang Wook Park; Min Jung Kwon; Ji Young Yoo; Hwa-Jung Choi; Young-Joon Ahn
Journal:  BMC Complement Altern Med       Date:  2014-05-26       Impact factor: 3.659

10.  [Rhinovirus and acute respiratory infections in hospitalized children. Retrospective study 1998-2000].

Authors:  V Guittet; J Brouard; A Vabret; F Lafay; B Guillois; J F Duhamel; F Freymuth
Journal:  Arch Pediatr       Date:  2003-05       Impact factor: 1.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.